Manoj Shah, VP IT, Amneal Pharmaceuticals
We started to look at cloud computing a few years ago out of necessity and it has gradually evolved to become an important part of our IT strategy.
Paul Shawah, VP, Commercial Cloud Strategy, Veeva Systems and President at Align Bio-pharma
The life science industry’s commercial model has transformed significantly over the past decade.
Charlton Park, Chief Analytics Officer at University of Utah Hospitals and Clinics
How to increase value is a question all health care providers are facing. The transformation that is necessary will require all providers to improve clinical outcomes.
Deborah Profit, PhD, Leader, Otsuka Information Technology (OIT), Otsuka Pharmaceutical Development & Commercialization
The healthcare industry, since outset, has been home to some of the most cutting-edge and forward-looking science, whether in biology, chemistry or genetics.
Michael Swanick, Global Pharmaceutical and Life Sciences Industry Leader, PwC
Technological advances, empowered consumers, disruptive new entrants, and rising demand by an aging population are ushering in a new era in healthcare
Jason Burke, System VP, Enterprise Analytics & Data Sciences, UNC Health Care
Why can we predict hurricanes and snow storms days to weeks in advance, but healthcare struggles to know what will be happening with patients tomorrow?
Abhishek Shankar, VP, Industry Head, Life Sciences Americas, HCL Technologies
The more things change, the more they remain the same. You could arguably apply this theory to the life sciences industry, whose core problems have remained pretty much the same over the last decade.
Bill Humphries, President, Merz North America Inc.
As the North American CEO of a global pharmaceutical company, I constantly face challenges that all CEOs face, with the additional challenge of dealing with an evolving regulatory landscape.
Terry Godier, Medical practitioner, mybiosource.com
ELISA is a popular acronym for an enzyme-linked immunosorbent test that detects as well as measures antibodies in the blood.
Dr. Chitra Lele, Chief Scientific Officer, Sciformix Corporation
Evidence-based medicine has been the mantra for patient treatment and public health for several decades.
